Erratum to: Eur Radiol DOI 10.1007/s00330-016-4437-9
Unfortunately, there is a mistake in the section Results, Clinical safety. While the text states that Bno severe AEs were reported^, in fact one severe AE was reported in the iomeprol group (one severe injection site pain assessed as possibly related to contrast agent), as shown in Table 5 . In addition, the name of the author Jean-François Paul was rendered incorrectly in the original publication but has since been corrected. The authors apologize for these mistakes.
